On 21 March 2018, orphan designation (EU/3/18/2005) was granted by the European Commission to Quintiles Ireland Limited, Ireland, for tazemetostat for the treatment of follicular lymphoma.
In May 2018, Quintiles Ireland Limited changed name to IQVIA RDS Ireland Limited.
The sponsorship was transferred to Voisin Consulting S.A.R.L., France, in June 2019.
|Disease / condition||
Treatment of follicular lymphoma
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;